BZUN
Baozun Inc.
There isn't enough reported data to score BZUN yet.
LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
BZUN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Weak |
BZUN's revenue is currently healthy, and its profitability and cash flow are stable, but its balance sheet is weak.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BZUN PE Valuation
BZUN has no meaningful PE right now: it lost money over the past year.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
BZUN Forward outlook
There aren't enough analyst estimates for BZUN to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BZUN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.35 | +$0.12 |
| Q1 2026 | -$0.49 | -$0.04 |
| Q4 2025 | -$0.63 | -$0.17 |
| Q3 2025 | -$0.53 | +$0.05 |
| Q2 2025 | -$0.47 | +$0.21 |
| Q1 2025 | -$0.45 | +$0.21 |
| Q4 2024 | -$0.46 | +$0.23 |
| Q3 2024 | -$0.58 | +$0.63 |
BZUN has the edge over LCID on earnings, with more consistent year-over-year improvement.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
BZUN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $410.5M | +7.2% |
| Q1 2026 | $357.3M | +15% |
| Q4 2025 | $476.1M | +5.9% |
| Q3 2025 | $323.6M | +4.8% |
| Q2 2025 | $383.1M | +6.8% |
| Q1 2025 | $309.8M | +4.3% |
| Q4 2024 | $449.4M | +7.7% |
| Q3 2024 | $308.7M | +13% |
BZUN's revenue has grown year over year for 13 quarters in a row: $410M last quarter, up 7.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 1.6% | +2 points |
| Q1 2026 | 0% | +4.1 points |
| Q4 2025 | 6.1% | +3.7 points |
| Q3 2025 | -1.2% | +4.4 points |
| Q2 2025 | -0.4% | +0.4 points |
| Q1 2025 | -4.1% | -1.3 points |
| Q4 2024 | 2.4% | +2.2 points |
| Q3 2024 | -5.6% | +1.9 points |
BZUN has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over BZUN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
BZUN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $40M | +$40M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
BZUN has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
BZUN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.4% | +823K shares |
| 1 year | +2% | +1.1M shares |
| 3 years | -0.6% | -335K shares |
| 5 years | -21% | -16M shares |
| Available history | -1.2% | -712K shares |
BZUN has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $1.5M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BZUN spent $2M buying back its own shares over the past year, after none the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
BZUN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | 141.2x | High |
| Q4 2024 | 12.1x | High |
| Q4 2021 | -6.6x | Net Cash |
| Q3 2021 | 2.6x | Moderate |
| Q2 2021 | -0.5x | Net Cash |
| Q1 2021 | -0.6x | Net Cash |
| Q4 2020 | -1.3x | Net Cash |
| Q3 2020 | -2.2x | Net Cash |
BZUN's net debt is more than 20 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BZUN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.4 | Neutral |
| Stochastic | 59.0 | Neutral |
BZUN's weekly RSI is 60 (neutral) and its Stochastic is 59 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BZUN PE vs Consumer Cyclical Sector
| Metric | BZUN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
BZUN has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
BZUN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 3.6% above |
| 20 week MA | $3.02 | 15% above |
| 50 week MA | $2.80 | 24% above |
| 100 week MA | $2.95 | 18% above |
| 200 week MA | $3.22 | 8.1% above |
BZUN has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
BZUN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $33.3 | $32.0 | -4% |
| 2021 | $32.0 | $14.0 | -56% |
| 2022 | $14.0 | $5.01 | -64% |
| 2023 | $5.01 | $2.74 | -45% |
| 2024 | $2.74 | $2.90 | +5.8% |
| 2025 | $2.90 | $2.70 | -6.9% |
| 2026 YTD | $2.70 | $3.48 | +29% |
BZUN has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.